Suppr超能文献

多巴反应性肌张力障碍及相关疾病的临床谱

Clinical spectrum of dopa-responsive dystonia and related disorders.

作者信息

Lee Woong-Woo, Jeon Beom Seok

机构信息

Movement Disorder Center, CRI, Seoul National University Hospital, Seoul, Korea.

出版信息

Curr Neurol Neurosci Rep. 2014 Jul;14(7):461. doi: 10.1007/s11910-014-0461-9.

Abstract

Dopa-responsive dystonia (DRD) has a classic presentation of childhood or adolescent-onset dystonia, mild parkinsonism, marked diurnal fluctuations, improvement with sleep or rest, and a dramatic and sustained response to low doses of L-dopa without motor fluctuations or dyskinesias. However, there have been many papers on patients with a wide range of features, which report them as DRD mainly because they had dystonic syndromes with L-dopa responsiveness. Many mutations in the dopaminergic system have been found as molecular genetic defects. Therefore, the clinical and genetic spectra of DRD are unclear, which lead to difficulties in diagnostic work-ups and planning treatments. We propose the concept of DRD and DRD-plus to clarify the confusion in this area and to help understand the pathophysiology and clinical features, which will help in guiding diagnostic investigations and planning treatments. We critically reviewed the literature on atypical cases and discussed the limitations of the gene study.

摘要

多巴反应性肌张力障碍(DRD)具有儿童期或青少年期起病的肌张力障碍、轻度帕金森症、明显的日间波动、睡眠或休息时改善以及对低剂量左旋多巴有显著且持续的反应而无运动波动或异动症等典型表现。然而,有许多关于具有广泛特征患者的论文,这些患者被报告为DRD主要是因为他们患有对左旋多巴有反应的肌张力障碍综合征。在多巴胺能系统中发现了许多突变作为分子遗传缺陷。因此,DRD的临床和遗传谱尚不清楚,这导致诊断检查和治疗规划存在困难。我们提出DRD和DRD加的概念以澄清该领域的混淆,并有助于理解病理生理学和临床特征,这将有助于指导诊断性研究和治疗规划。我们对非典型病例的文献进行了严格审查,并讨论了基因研究的局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eec4/4061475/260d4f3ea3e7/11910_2014_461_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验